The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Detailed price information for 4D Molecular Therapeutics Inc (FDMT-Q) from The Globe and Mail including charting and trades.

4D Molecular Therapeutics, Inc. (FDMT) shares soared 7.9% in the last trading session to close at $10.42. The move was backed by solid volume with far more shares changing hands than in a normal ...

Okay. Well, thank you, everyone, for joining us. We are here with FDMT. Kristian Humer, CFO; and Chris Simms, CCO and CBO. Maybe you could start with an overview of your directed evolution gene ...

DIYer and woodworker April Wilkerson walks you through the step-by-step process of crafting a custom wooden growth chart ruler to beautifully document your children's milestones over the years.

Detailed price information for 4D Molecular Therapeutics Inc (FDMT-Q) from The Globe and Mail including charting and trades.

D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment ...

D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment ...

FRONT-2 global enrollment completed approximately 4 months ahead of initial projections4FRONT-2 over-enrolled (anticipated N>500), with final patient randomization expected in Q3 2026, reflecting ...

Ocugen has no product revenue, remains loss-making, and the convertible notes add debt burden and potential share dilution.